Robert E Conway
Director at Alpine Immune Sciences, Inc. (ALPN)
Robert E Conway has filed 11 insider reports with the SEC since May 2021, as director at Alpine Immune Sciences, Inc. (ALPN) and chairman of the Board and director at ARCA biopharma, Inc. (ORKA). Robert E Conway made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2024, reports sale back to the company at Alpine Immune Sciences, Inc. (ALPN).
- Filings
- 11
- Companies
- 2
- Bought on market
- $313K
- Sold on market
- None
Companies where Robert E Conway is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $249K | $9.96 | May 21, 2024 | ||||
| Chairman of the Board, Director | 50,000 | $64.3K | $3.21 | $96.32+2901% | Jan 31, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- May 20, 2024ALPNConway Robert E returned 50,000 shares to the companyForm 4Sale back to the company
- Jan 30, 2024ORKASEC Form 4 filed by Conway Robert EForm 4Grant or award
- Jan 2, 2024ALPNSEC Form 4 filed by Conway Robert EForm 4Grant or award
- Jan 3, 2023ALPNSEC Form 4 filed by Conway Robert EForm 4Grant or award
- Dec 15, 2022ORKASEC Form 4 filed by Conway Robert EForm 4Grant or award
- Jan 3, 2022ALPNSEC Form 4 filed by Conway Robert EForm 4Grant or award
- Sep 23, 2021+$151KALPNSEC Form 4: Conway Robert E bought $151,154 worth of shares (15,000 units at $10.08) (Amendment)Form 4Open-market purchase
- Sep 23, 2021ALPNSEC Form 4 filed by Conway Robert EForm 4Open-market sale
- Sep 21, 2021+$98KALPNSEC Form 4: Conway Robert E bought $97,966 worth of Common Stock (10,000 units at $9.80)Form 4Open-market purchase
- May 12, 2021+$31.9KORKASEC Form 4: CONWAY ROBERT E bought $31,947 worth of Common Stock (10,000 units at $3.19), increasing direct ownership by 25% to 50,000 unitsForm 4Open-market purchase
- May 5, 2021+$32.3KORKASEC Form 4: CONWAY ROBERT E bought $32,345 worth of Common Stock (10,000 units at $3.23), increasing direct ownership by 33% to 40,000 unitsForm 4Open-market purchase
Compare Robert E Conway with
- Robert E Conway vs Joana Goncalves1 shared
- Robert E Conway vs Arjun Agarwal1 shared
- Robert E Conway vs Kristine M Ball1 shared
- Robert E Conway vs Lawrence Otto Klein1 shared
- Robert E Conway vs Paul T Quinlan1 shared
- Robert E Conway vs Laura Lee Sandler1 shared
Other insiders at the same companies
- Joana GoncalvesORKA
- Arjun AgarwalORKA
- Kristine M BallORKA
- Lawrence Otto KleinORKA
- Paul T QuinlanORKA
- Laura Lee SandlerORKA
- Larry Todd EdwardsORKA
- Fairmount Funds Management LLCORKA
- Carl DambkowskiORKA
- Samarth KulkarniORKA
- Christopher Nathan MartinORKA
- Cameron TurtleORKA
- Venrock Healthcare Capital Partners III, L.P.ORKA
Questions about Robert E Conway
- What is Robert E Conway's role at Alpine Immune Sciences, Inc.?
- Robert E Conway reports to the SEC as director at Alpine Immune Sciences, Inc. (ALPN), according to the latest filing on May 21, 2024. Robert E Conway has also filed as chairman of the Board and director at ARCA biopharma, Inc. (ORKA).
- How many shares does Robert E Conway own?
- After the latest filing that states it, Robert E Conway directly owned 50,000 shares of ARCA biopharma, Inc. (ORKA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E Conway bought or sold stock recently?
- The most recent open-market purchase was on September 23, 2021: bought 15,000 shares of Alpine Immune Sciences, Inc. (ALPN) for $151K at an average of $10.08.
- How do I get alerts when Robert E Conway files?
- Follow Robert E Conway on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert E Conway (SEC CIK 0001184334). Totals count each trade once, skipping amendments whose original is on file, from May 6, 2021 on. View on SEC EDGAR